|
1
|
Stout AP and Murray MR:
Hemangiopericytoma: A vascular tumor featuring zimmermann's
pericytes. Ann Surg. 116:26–33. 1942. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang ZY, Qiu K, Ma YH, Wang XT, Bao JJ,
Zhang ZF and Liu XZ: Intracranial solitary fibrous tumors: A report
of two cases and a review of the literature. Oncol Lett.
11:1057–1060. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamashita D, Suehiro S, Kohno S, Ohue S,
Nakamura Y, Kouno D, Ohtsuka Y, Nishikawa M, Matsumoto S, Bernstock
JD, et al: Intracranial anaplastic solitary fibrous
tumor/hemangiopericytoma: Immunohistochemical markers for
definitive diagnosis. Neurosurg Rev. 44:1591–1600. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fritchie K, Jensch K, Moskalev EA, Caron
A, Jenkins S, Link M, Brown PD, Rodriguez FJ, Guajardo A, Brat D,
et al: The impact of histopathology and NAB2-STAT6 fusion subtype
in classification and grading of meningeal solitary fibrous
tumor/hemangiopericytoma. Acta Neuropathol. 137:307–319. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Georgiesh T, Namløs HM, Sharma N, Lorenz
S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA and Boye K: Clinical
and molecular implications of NAB2-STAT6 fusion variants in
solitary fibrous tumour. Pathology. 53:713–719. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim BS, Kim Y, Kong DS, Nam DH, Lee JII,
Suh YL and Seol HJ: Clinical outcomes of intracranial solitary
fibrous tumor and hemangiopericytoma: Analysis according to the
2016 WHO classification of central nervous system tumors. J
Neurosurg. 129:1384–1396. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shin DW, Kim JH, Chong S, Song SW, Kim YH,
Cho YH, Hong SH and Nam SJ: Intracranial solitary fibrous
tumor/hemangiopericytoma: Tumor reclassification and assessment of
treatment outcome via the 2016 WHO classification. J Neuroncol.
154:171–178. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frazier AA: The yin and yang of solitary
fibrous tumor. Radiographics. 34:2942014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang H, Zhang Y, Zheng T, Li C, Tang G and
Chen G: A solitary fibrous tumor/hemangiopericytoma of the fourth
ventricle: Case report and literature review. J Int Med Res.
47:6349–6355. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clarençon F, Bonneville F, Rousseau A,
Galanaud D, Kujas M, Naggara O, Cornu P and Chiras J: Intracranial
solitary fibrous tumor: Imaging findings. Eur J Radiol. 80:387–394.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ronchi A, Cozzolino I, Marino FZ, Accardo
M, Montella M, Panarese I, Roccuzzo G, Toni G, Franco R and De
Chiara A: Extrapleural solitary fibrous tumor: A distinct entity
from pleural solitary fibrous tumor. An update on clinical,
molecular and diagnostic features. Ann Diagn Pathol. 34:142–150.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma L, Wang L, Fang X, Zhao CH and Sun L:
Diagnosis and treatment of solitary fibrous
tumor/hemangiopericytoma of central nervous system. Retrospective
report of 17 patients and literature review. Neuro Endocrinol Lett.
39:88–94. 2018.PubMed/NCBI
|
|
14
|
Kallen ME and Hornick JL: The 2020 WHO
classification: What's new in soft tissue tumor pathology? Am J
Surg Pathol. 45:e1–e23. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang SC and Huang HY: Solitary fibrous
tumor: An evolving and unifying entity with unsettled issues.
Histol Histopathol. 34:313–334. 2019.PubMed/NCBI
|
|
16
|
Buerki RA, Horbinski CM, Kruser T,
Horowitz PM, James CD and Lukas RV: An overview of meningiomas.
Future Oncol. 14:2161–2177. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Doyle LA, Vivero M, Fletcher CD, Mertens F
and Hornick JL: Nuclear expression of STAT6 distinguishes solitary
fibrous tumor from histologic mimics. Mod Pathol. 27:390–395. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schweizer L, Koelsche C, Sahm F, Piro RM,
Capper D, Reuss DE, Pusch S, Habel A, Meyer J, Göck T, et al:
Meningeal hemangiopericytoma and solitary fibrous tumors carry the
NAB2-STAT6 fusion and can be diagnosed by nuclear expression of
STAT6 protein. Acta Neuropathol. 125:651–658. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshida A, Tsuta K, Ohno M, Yoshida M,
Narita Y, Kawai A, Asamura H and Kushima R: STAT6
immunohistochemistry is helpful in the diagnosis of solitary
fibrous tumors. Am J Surg Pathol. 38:552–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Louis DN, Perry A, Wesseling P, Brat DJ,
Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM,
Reifenberger G, et al: The 2021 WHO classification of tumors of the
central nervous system: A summary. Neuro Oncol. 23:1231–1251. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barresi V, Caffo M and Tuccari G:
Classification of human meningiomas: Lights, shadows, and future
perspectives. J Neurosci Res. 94:1604–1612. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Apra C, Mokhtari K, Cornu P, Peyre M and
Kalamarides M: Intracranial solitary fibrous
tumors/hemangiopericytomas: First report of malignant progression.
J Neurosurg. 128:1719–1724. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramakrishna R, Rostomily R, Sekhar L,
Rockhill J and Ferreira M: Hemangiopericytoma: Radical resection
remains the cornerstone of therapy. J Clin Neurosci. 21:612–615.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patel SR, Vachhani P and Moeslein F:
Embolic brain infarcts: A rare fatal complication of preoperative
embolization of a massive solitary fibrous tumor of the pleura.
Cardiovasc Intervent Radiol. 40:306–309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sonabend AM, Zacharia BE, Goldstein H,
Bruce SS, Hershman D, Neugut AI and Bruce JN: The role for adjuvant
radiotherapy in the treatment of hemangiopericytoma: A
surveillance, epidemiology, and end results analysis. J Neurosurg.
120:300–308. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hashida S, Yokota H, Oyama Y, Kawakami M,
Murakami S and Kawakami H: Bulky cardiac metastasis of intracranial
solitary fibrous tumor/hemangiopericytoma: Delayed metastasis after
cranial tumor resection. Radiol Case Rep. 14:1175–1180. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakada S, Minato H, Takegami T, Kurose N,
Ikeda H, Kobayashi M, Sasagawa Y, Akai T, Kato T, Yamamoto N and
Nojima T: NAB2-STAT6 fusion gene analysis in two cases of meningeal
solitary fibrous tumor/hemangiopericytoma with late distant
metastases. Brain Tumor Pathol. 32:268–274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu Z, Yang H, Weng D and Ding Y: Rapid
recurrence and bilateral lungs, multiple bone metastasis of
malignant solitary fibrous tumor of the right occipital lobe:
Report of a case and review. Diagn Pathol. 10:912015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Damodaran O, Robbins P, Knuckey N,
Bynevelt M, Wong G and Lee G: Primary intracranial
haemangiopericytoma: Comparison of survival outcomes and metastatic
potential in WHO grade II and III variants. J Clin Neurosci.
21:1310–1314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Giordan E, Marton E, Wennberg AM,
Guerriero A and Canova G: A review of solitary fibrous
tumor/hemangiopericytoma tumor and a comparison of risk factors for
recurrence, metastases and death among patients with spinal and
intracranial tumors. Neurosurg Rev. 44:1299–1312. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Patel AR, Flores BC, Ban VS, Hatanpaa KJ,
Mickey BE and Barnett SL: Intracranial hemangiopericytomas:
Recurrence, metastasis, and radiotherapy. J Neurol Surg B Skull
Base. 78:324–330. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ali HSM, Endo T, Endo H, Murakami K and
Tominaga T: Intraspinal dissemination of intracranial
hemangiopericytoma: Case report and literature review. Surg Neurol
Int. 7 (Suppl 40):S1016–S1020. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Demicco EG, Park MS, Araujo DM, Fox PS,
Bassett RL, Pollock RE, Lazar AJ and Wang WL: Solitary fibrous
tumor: A clinicopathological study of 110 cases and proposed risk
assessment model. Mod Pathol. 25:1298–1306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Demicco EG, Wagner MJ, Maki RG, Gupta V,
Iofin I, Lazar AJ and Wang WL: Risk assessment in solitary fibrous
tumors: Validation and refinement of a risk stratification model.
Mod Pathol. 30:1433–1442. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schiariti M, Goetz P, El-Maghraby H,
Tailor J and Kitchen N: Hemangiopericytoma: Long-term outcome
revisited. Clinical article. J Neurosurg. 114:747–755. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen LF, Yang Y, Yu XG, Gui QP, Xu BN and
Zhou DB: Multimodal treatment and management strategies for
intracranial hemangiopericytoma. J Clin Neurosci. 22:718–725. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Anderson WJ and Doyle LA: Updates from the
2020 world health organization classification of soft tissue and
bone tumours. Histopathology. 78:644–657. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
von Mehren M, Kane JM, Bui MM, Choy E,
Connelly M, Dry S, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, et
al: NCCN guidelines insights: Soft tissue sarcoma, version 1.2021.
J Natl Compr Canc Netw. 18:1604–1612. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hajdu M, Singer S, Maki RG, Schwartz GK,
Keohan ML and Antonescu CR: IGF2 over-expression in solitary
fibrous tumours is independent of anatomical location and is
related to loss of imprinting. J Pathol. 221:300–307. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamada Y, Kohashi K, Fushimi F, Takahashi
Y, Setsu N, Endo M, Yamamoto H, Tokunaga S, Iwamoto Y and Oda Y:
Activation of the Akt-mTOR pathway and receptor tyrosine kinase in
patients with solitary fibrous tumors. Cancer. 120:864–876. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stacchiotti S, Negri T, Libertini M,
Palassini E, Marrari A, Troia BD, Gronchi A, Tos APD, Morosi C,
Messina A, et al: Sunitinib malate in solitary fibrous tumor (SFT).
Ann Oncol. 23:3171–3179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Machado I, Nieto-Morales G, Cruz J,
Navarro S, Giner F, Ferrandez A, López-Soto MV, Lavernia J and
Llombart-Bosch A: Controversial issues in soft tissue solitary
fibrous tumors: A pathological and molecular review. Pathol Int.
70:129–139. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sawada N, Ishiwata T, Naito Z, Maeda S,
Sugisaki Y and Asano G: Immunohistochemical localization of
endothelial cell markers in solitary fibrous tumor. Pathol Int.
52:769–776. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Biermann JS, Chow W, Reed DR, Lucas D,
Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, et
al: NCCN guidelines insights: Bone cancer, version 2.2017. J Natl
Compr Canc Netw. 15:155–167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Maruzzo M, Martin-Liberal J, Messiou C,
Miah A, Thway K, Alvarado R, Judson I and Benson C: Pazopanib as
first line treatment for solitary fibrous tumours: The royal
marsden hospital experience. Clin Sarcoma Res. 5:52015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Park MS, Ravi V and Araujo DM: Inhibiting
the VEGF-VEGFR pathway in angiosarcoma, epithelioid
hemangioendothelioma, and hemangiopericytoma/solitary fibrous
tumor. Curr Opin Oncol. 22:351–355. 2010. View Article : Google Scholar : PubMed/NCBI
|
